Journal of Lipid Research, Vol 31, 1477-1482, Copyright © 1990 by Lipid Research, Inc.

ARTICLES

Clofibrate-inducible rat hepatic P450s IVA1 and IVA3 catalyze the omega- and (omega-1)-hydroxylation of fatty acids and the omega-hydroxylation of prostaglandins E1 and F2 alpha

T Aoyama, JP Hardwick, S Imaoka, Y Funae, HV Gelboin and FJ Gonzalez
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

Cytochromes P450IVA1 and IVA3 display 72% amino acid sequence similarity and are expressed in livers of rats treated with the hypolipidemic drug clofibrate. The catalytic activities of IVA1 and IVA3 were examined by cDNA-directed expression using vaccinia virus. cDNA-expressed IVA1 and IVA3 had relative Mrs of 51,500 and 52,000, respectively, on SDS-polyacrylamide gels. Both enzymes displayed reduced, CO-bound absorption spectra with lambda max of 452.5 nm. IVA1 and IVA3 hydroxylated lauric acid at the omega and omega-1 positions with equivalent omega/omega-1 ratios of about 12.5. IVA1 had a substrate turnover of 21 min-1 which was about fourfold higher than that of IVA3. The omega and omega-1 hydroxylation of palmitic acid was also catalyzed by these P450s with combined turnover numbers for both metabolites of 45 min-1 or 18 min-1 for IVA1 and IVA3, respectively. The omega/omega-1 oxidation ratio of IVA1 for palmitate was 1.25 which was almost fourfold higher than that obtained for IVA3. These enzymes also catalyzed omega oxidation of the physiologically important eicosanoids prostaglandins E1 and F2 alpha with turnover numbers of about one-tenth those calculated for fatty acid oxidations. No omega-1 hydroxy metabolites were produced. These studies indicate that the P450 enzymes IVA1 and IVA3 are able to catalyze the oxidations of both fatty acids and prostaglandins.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Zhang, M.-H. Wang, J.-S. Wang, B. Zand, V. R. Gopal, J. R. Falck, M. Laniado-Schwartzman, and A. Nasjletti Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1089 - H1095. [Abstract] [Full Text] [PDF]

				S. S. Chuang, C. Helvig, M. Taimi, H. A. Ramshaw, A. H. Collop, M.'a. Amad, J. A. White, M. Petkovich, G. Jones, and B. Korczak CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes {omega}- and ({omega}-1)-Hydroxylation of Fatty Acids J. Biol. Chem., February 20, 2004; 279(8): 6305 - 6314. [Abstract] [Full Text] [PDF]

				R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]

				D. GERHOLD, M. LU, J. XU, C. AUSTIN, C. T. CASKEY, and T. RUSHMORE Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays Physiol Genomics, April 27, 2001; 5(4): 161 - 170. [Abstract] [Full Text] [PDF]

				T. Nakajima, Y. Kamijo, N. Usuda, Y. Liang, Y. Fukushima, K. Kametani, F. J. Gonzalez, and T. Aoyama Sex-dependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}) Carcinogenesis, April 1, 2000; 21(4): 677 - 682. [Abstract] [Full Text] [PDF]

				D. H. Munzenmaier and D. R. Harder Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1163 - H1167. [Abstract] [Full Text] [PDF]

				F. Adas, J. P. Salaün, F. Berthou, D. Picart, B. Simon, and Y. Amet Requirement for {omega} and ({omega};-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11 J. Lipid Res., November 1, 1999; 40(11): 1990 - 1997. [Abstract] [Full Text]

				X. Nguyen, M.-H. Wang, K. M. Reddy, J. R. Falck, and M. L. Schwartzman Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1691 - R1700. [Abstract] [Full Text] [PDF]

				M.-H. Wang, H. Guan, X. Nguyen, B. A. Zand, A. Nasjletti, and M. Laniado-Schwartzman Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys Am J Physiol Renal Physiol, February 1, 1999; 276(2): F246 - F253. [Abstract] [Full Text] [PDF]

				F. Guéraud, J. Alary, P. Costet, L. Debrauwer, L. Dolo, T. Pineau, and A. Paris In vivo involvement of cytochrome P450 4A family in the oxidative metabolism of the lipid peroxidation product trans-4-hydroxy-2-nonenal, using PPAR{alpha}-deficient mice J. Lipid Res., January 1, 1999; 40(1): 152 - 159. [Abstract] [Full Text]

				D. L. Kroetz, P. Yook, P. Costet, P. Bianchi, and T. Pineau Peroxisome Proliferator-activated Receptor alpha  Controls the Hepatic CYP4A Induction Adaptive Response to Starvation and Diabetes J. Biol. Chem., November 20, 1998; 273(47): 31581 - 31589. [Abstract] [Full Text] [PDF]

				O. Ito, M. Alonso-Galicia, K. A. Hopp, and R. J. Roman Localization of cytochrome P-450 4A isoforms along the rat nephron Am J Physiol Renal Physiol, February 1, 1998; 274(2): F395 - F404. [Abstract] [Full Text] [PDF]

				D. L. Kroetz, L. M. Huse, A. Thuresson, and M. P. Grillo Developmentally Regulated Expression of the CYP4A Genes in the Spontaneously Hypertensive Rat Kidney Mol. Pharmacol., September 1, 1997; 52(3): 362 - 372. [Abstract] [Full Text]

				C.-Y. Fan, J. Pan, R. Chu, D. Lee, K. D. Kluckman, N. Usuda, I. Singh, A. V. Yeldandi, M. S. Rao, N. Maeda, et al. Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene J. Biol. Chem., October 4, 1996; 271(40): 24698 - 24710. [Abstract] [Full Text] [PDF]

				T. Hashimoto, W. S. Cook, C. Qi, A. V. Yeldandi, J. K. Reddy, and M. S. Rao Defect in Peroxisome Proliferator-activated Receptor alpha -inducible Fatty Acid Oxidation Determines the Severity of Hepatic Steatosis in Response to Fasting J. Biol. Chem., September 8, 2000; 275(37): 28918 - 28928. [Abstract] [Full Text] [PDF]